Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

407 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. Tashkin DP, et al. Among authors: decramer m. N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5. N Engl J Med. 2008. PMID: 18836213 Clinical Trial.
Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study.
Decramer ML, Chapman KR, Dahl R, Frith P, Devouassoux G, Fritscher C, Cameron R, Shoaib M, Lawrence D, Young D, McBryan D; INVIGORATE investigators. Decramer ML, et al. Lancet Respir Med. 2013 Sep;1(7):524-33. doi: 10.1016/S2213-2600(13)70158-9. Epub 2013 Aug 21. Lancet Respir Med. 2013. PMID: 24461613 Clinical Trial.
Cardiovascular safety of tiotropium in patients with COPD.
Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin DP. Celli B, et al. Among authors: decramer m. Chest. 2010 Jan;137(1):20-30. doi: 10.1378/chest.09-0011. Epub 2009 Jul 10. Chest. 2010. PMID: 19592475
407 results